title: [Genetic polymorphisms associated with thrombophilia and risk for developing HELLP syndrome].
authors: Pablo
authors: P
authors: Stiefel
authors: María Luisa
authors: ML
authors: Miranda
authors: Félix
authors: F
authors: Gómez De Rueda
authors: Rocío
authors: R
authors: Muñoz-Hernández
mesh_terms: D020016:Activated Protein C Resistance / Q000453:epidemiology / Q000235:genetics; D018450:Disease Progression; D005165:Factor V / Q000235:genetics; D005260:Female; D020022:Genetic Predisposition to Disease; D017359:HELLP Syndrome / Q000453:epidemiology / Q000209:etiology / Q000235:genetics*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000453:epidemiology / Q000235:genetics; D008055:Lipids / Q000097:blood; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics; D018384:Oxidative Stress / Q000235:genetics; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D011225:Pre-Eclampsia / Q000097:blood*; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011401:Promoter Regions, Genetic / Q000235:genetics; D011516:Prothrombin / Q000235:genetics; D012306:Risk; D013030:Spain / Q000453:epidemiology; D019851:Thrombophilia / Q000453:epidemiology / Q000209:etiology / Q000235:genetics*
chemical_list: D008055:Lipids; D017395:Plasminogen Activator Inhibitor 1; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin; D042965:Methylenetetrahydrofolate Reductase (NADPH2)